Francis C W, Marder V J, Martin S E
Blood. 1980 Sep;56(3):456-64.
Plasmic degradation of crosslinked fibrin has been studied to identify the proteolytic cleavages that convert the clot into a soluble lysate and also to identify the derivatives that are likely to circulate during clot dissolution. Initial polypeptide chain cleavages do not disrupt the solid clot matrix. With continued exposure to plasmin, high molecular weight derivatives are produced that remain attached to the clot by noncovalent forces. Further degradation then results in the liberation into solution of several large, noncovalently bound complexes. Progressive degradation of the largest, initially liberated complexes to the terminal derivatives, DD/E, DD, and E, occurs in solution after their release from the clot. As the fibrin clot is exposed to plasmin for longer intervals, progressive dissolution occurs, but the structure of the covalently bound insoluble fibrin core, the noncovalently attached derivatives, and the liberated complexes remains constant. Since much of the initially liberated protein is in complexes larger than DD/E, these derivatives probably represent the more prevalent plasmic degradation products of crosslinked fibrin in vivo.
已对交联纤维蛋白的血浆降解进行了研究,以确定将凝块转化为可溶性裂解产物的蛋白水解切割,并确定在凝块溶解过程中可能循环的衍生物。最初的多肽链切割不会破坏固体凝块基质。随着持续暴露于纤溶酶,会产生高分子量衍生物,这些衍生物通过非共价力与凝块相连。进一步降解会导致几种大的、非共价结合的复合物释放到溶液中。最初释放的最大复合物逐步降解为末端衍生物DD/E、DD和E,这在它们从凝块释放后在溶液中发生。随着纤维蛋白凝块暴露于纤溶酶的时间间隔延长,会发生逐步溶解,但共价结合的不溶性纤维蛋白核心、非共价附着的衍生物和释放的复合物的结构保持不变。由于最初释放的大部分蛋白质存在于大于DD/E的复合物中,这些衍生物可能代表体内交联纤维蛋白更普遍的血浆降解产物。